| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104.8M | — | +19.5% |
| R&D Expense | $18.2M | — | +10.5% |
| SG&A Expense | $29.8M | — | +4.9% |
| Operating Income | $34.8M | — | +52.5% |
| Interest Expense | $8.5M | — | -19.7% |
| Pre-tax Income | $28.0M | — | +101.3% |
| Income Tax | $5.2M | — | +149.8% |
| Net Income | $22.8M | — | +92.8% |
| EPS (Basic) | $0.21 | — | +90.9% |
| EPS (Diluted) | $0.20 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $53.3M | -27.1% | -36.7% |
| Short-term Investments | $62.4M | -1.8% | +93.2% |
| Accounts Receivable | $32.6M | +13.8% | +14.5% |
| Current Assets | $281.3M | -7.4% | +6.9% |
| Total Assets | $1.00B | -3.6% | -7.8% |
| Current Liabilities | $81.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $58.5M | — | +2.4% |
| Capital Expenditures | $434K | — | +90.4% |
| Investing Cash Flow | -$4.9M | — | +20.8% |
| Financing Cash Flow | -$73.4M | — | -61.0% |
| Free Cash Flow | $58.1M | — | +2.0% |
| -8.9% |
| Long-term Debt | $391.3M | -6.5% | -14.8% |
| Total Liabilities | $535.8M | -4.1% | -23.2% |
| Stockholders' Equity | $466.6M | -2.9% | +19.8% |